Saffron
Crocus sativus L. · the dried threads of the saffron crocus, the world's most expensive spice
ConditionalScroll for the verdict ↓
If you're considering saffron, ask one question first: is this for diagnosed mild-to-moderate low mood, or for weight loss? If it's mood, a standardized 30 mg/day extract for 6+ weeks is a reasonable low-risk adjunct alongside real care. If it's weight or appetite, save your money — that's the part that doesn't work.
Saffron's active compounds nudge serotonin, the same brain chemical SSRIs act on, which is why in head-to-head trials it lands in roughly the same place as those drugs for mild depression. But the studies are small and mostly from one country, and most saffron sold is faked with cheaper plants, so the bottle often can't deliver the effect.
That's the general answer. Your stack is different.
Check your whole stackCrocus sativus L. · the dried threads of the saffron crocus, the world's most expensive spice
ConditionalBefore you buy saffron, ask: is this for low mood, or for weight loss? For diagnosed mild-to-moderate low mood, a standardized 30 mg/day extract for six weeks is a reasonable low-risk add-on. For weight or appetite, save your money.
Saffron has real antidepressant trials behind it, but the weight-loss and "appetite control" claims fail their most direct test.
One decision. No equipment needed.
The Verdict
Saffron works like a mild antidepressant for low mood, but only if you buy the real thing.
Saffron is the dried red threads of a flower, taken as a supplement mostly for mood. Its active compounds nudge serotonin, the same brain chemical that antidepressant drugs act on, which is why in head-to-head trials saffron lands in roughly the same place as those drugs for mild depression. The catch is that the studies are small and mostly from one country, and most saffron sold is faked with cheaper plants, so the bottle often can't deliver the effect.
Adults with diagnosed mild-to-moderate low mood who want a low-risk add-on alongside real care.
You're healthy with no condition, chasing fat loss, or can only get culinary or unverified saffron.
Want the full evidence? Keep scrolling
The Protocol
One dose dominates the research: 30 mg/day of a standardized extract. Saffron is unusual in having a tight, well-defined effective dose, and there is no proven benefit to going higher for mood.
| Use | Dose | Timing | Form |
|---|---|---|---|
| Mild-to-moderate depression | 30 mg/day (split AM/PM) | Daily, 6+ weeks | Standardized extract |
| Anxiety | 30 mg/day | Daily | Standardized extract |
| Sleep / insomnia | 14-30 mg/day | Evening | Standardized extract |
| T2D / metabolic syndrome | ~30 mg/day | With meals | Powder or extract |
Safety & Interactions
At the studied 30 mg/day dose saffron is well tolerated, with side-effect rates near placebo. The real safety levers are interactions and a narrow margin to its toxic dose, not organ harm at supplement doses.
Saffron acts on serotonin, the same pathway, so there is a theoretical additive load. Combine only under clinician oversight.
Small additive glucose and blood-pressure lowering. Monitor if you stack it on medication.
Upper limit: no formal limit, but adverse effects appear above ~1.5 g/day and ~5 g is toxic. The 30 mg dose sits well below that, but gram-level dosing is genuinely dangerous, so more is not better.
Conviction
Endpoint-stratified. Mild-to-moderate depression earns a genuine MODERATE: real, repeated, and on par with SSRIs in head-to-head pooling. Every other claim (weight, appetite, inflammation, blood pressure, cognition) is trivial or null.
Go Deeper
Want to stop wasting money on supplements that don't work? The Verdict reviews one every week, with the evidence graded in plain English. Free.
Get weekly verdicts
"A natural mood-lifter and antidepressant without the side effects, plus appetite control, better sleep, and blood-sugar balance, backed by a thousand years of traditional use."
The mood claim deserves to be stated fairly, because it has real substance: there genuinely are randomized trials and repeated meta-analyses showing saffron beats placebo for mild-to-moderate depression and performs comparably to standard antidepressants. That is a stronger track record than almost any other herbal supplement can claim. The appetite, weight, and metabolic claims borrow credibility from the mood data, which is where the marketing runs ahead of the evidence.
| Claim | Conviction | What the data shows |
|---|---|---|
| Mild-to-moderate depression | MODERATE | Beats placebo, comparable to SSRIs head-to-head (Hausenblas 2013; PMID 30036891; PMID 38913392). Capped below HIGH by small, mostly-Iranian trials. |
| Anxiety | LOW-MOD | Improved, usually co-measured with mood (PMID 38913392, 38424688). |
| Sleep / insomnia | LOW-MOD | PSQI improved, but very-low-quality GRADE and high inconsistency (PMID 35325766, 36141931). |
| T2D / metabolic glucose | MODERATE | Small fasting-glucose drop (~6.7 mg/dL) in dysmetabolic people; surrogate, not outcome (PMID 39931766). |
| Blood pressure | LOW | Statistically real, clinically tiny (SBP -0.65, DBP -1.23 mmHg; PMID 34444896). |
| Weight / appetite | LOW | 25-RCT obesity meta-analysis: -0.32 kg, nonsignificant (PMID 35866520). Doesn't work. |
| Inflammation | LOW | No significant pooled CRP/TNF-α/IL-6 change (PMID 32525606). |
| Cognition / dementia | LOW | Mixed, small, contested (PMID 33167948). |
| Healthy adults, no condition | NONE | Nothing to move. |
Saffron's activity comes from its carotenoids and their breakdown products: crocin and crocetin (the red-orange pigments) and safranal (the aroma compound). For mood, the leading mechanism is serotonergic. Crocin and safranal appear to slow serotonin reuptake, the same action SSRIs have, which fits the finding that saffron and those drugs land in the same place for mild depression.
One honest caveat: a large share of saffron's mechanism research is in animals and cells. The serotonin story is coherent and matches the clinical direction, but mechanism is not proof of effect. Saffron earns its mood verdict from the human trials, not the pathway diagrams. Note too that crocin is poorly absorbed and largely converted to crocetin in the gut, so "crocin content" on a label is a weaker quality marker than it sounds.
Not a real conflict. "No difference vs SSRI" is non-inferiority in small trials, the favorable reading for a herbal, but it is not proven superiority, and it came from mild-to-moderate cases, not severe depression.
Bundling two herbs in one review inflates saffron's apparent glucose effect. On its own, saffron's glycemic signal is small.
Lab studies use authenticated, standardized saffron. Saffron is one of the most counterfeited foods on earth, routinely cut with safflower, turmeric, or dyed fibers, so a consumer's jar may contain little real saffron and never deliver the dose that works.
The evidence is dominated by small, predominantly Iranian trials with the publication bias common to herbal research, and the dominant mood and appetite trials use manufacturer-linked branded extracts. Assume the true effect is at or below the trial estimate.
The antidepressant data are for 30 mg/day of standardized extract, not a pinch in cooking. Casual culinary use has no mood evidence.
Who benefits most: adults with diagnosed mild-to-moderate depression (the clearest evidence), then those with mild anxiety, poor sleep, or a dysmetabolic profile wanting a low-risk adjunct.
Cost and food-first: a standardized extract runs roughly £12-25 a month. There is no food substitute that delivers the mood effect, because culinary saffron does not reach the clinical dose. If your goal is general wellbeing rather than treating low mood, this is not where your money goes first.
Sources
Evidence-scored dosing, timing, forms, and who should skip it. One page, no fluff.
Get the protocolConviction-scored verdicts on supplements, nutrition, training, physio, and recovery.